CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale Director sold 25,000 shares at an average $82.80 ($2,070,050)
- 4 Open-market sale SVP & Chief Financial Officer sold 90,000 shares at an average $84.05 ($7,564,200)
- 4 Open-market sale President & CEO sold 130,000 shares at an average $84.05 ($10,926,066)
- 4 Exercise or conversion Director acquired 30,000 shares (option exercise)
- 4 Open-market sale SVP & Chief Accounting Officer sold 13,881 shares at $101.46 ($1,408,366)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 502 shares at $105.67 ($53,046)
- 4 Open-market sale Director sold 30,000 shares at $101.74 ($3,052,200)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 29,498 shares at an average $102.81 ($3,032,765)
- 4 Open-market sale Director sold 30,000 shares at $92.22 ($2,766,600)
- 4 Open-market sale SVP & Chief Scientific Officer sold 160,000 shares at an average $93.06 ($14,890,180)
- 4 Open-market sale Director sold 25,000 shares at an average $92.14 ($2,303,600)
- 4 Open-market sale Director sold 40,000 shares at an average $97.60 ($3,903,914)
- 4 Open-market sale SVP & Chief Operating Officer sold 220,144 shares at an average $99.27 ($21,854,265)
- 4 Open-market sale SVP & Chief Accounting Officer sold 2,545 shares at $82.94 ($211,082)
- 4 Open-market sale President & CEO sold 12,788 shares at $82.94 ($1,060,637)
- 4 Open-market sale SVP & Chief Operating Officer sold 4,879 shares at $82.94 ($404,664)
- 4 Open-market sale SVP & Chief Financial Officer sold 3,477 shares at $82.94 ($288,382)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,875 shares at $82.94 ($238,453)
- 4 Open-market sale SVP & Chief Scientific Officer sold 2,426 shares at $82.94 ($201,212)
- 4 Exercise or conversion SVP & Chief Operating Officer acquired 120,000 shares (option exercise)
Page 18 of 49 · 970 filings